Abstract: This invention is in the field of medical intervention related to the lacrimal system. The invention relates to a lacrimal system device or system and methods of using the device for drug delivery to the eye, sinuses and/or periocular tissues.

Abstract: A wearable treatment and analysis module is provided. The module is positioned on or near a body surface region of interest. The module provides remote access to sensor data, treatment administration, and/or other health care regimens via a network connection with a user device and/or management system.

Abstract: Garment-like absorbent articles are disclosed. The garment-like absorbent articles may include two nonwoven components that have coordinating and/or substantially similar repeat patterns of apertures and/or bonds. The two nonwoven components may also have certain repeat unit areas, repeat unit width, and repeat unit lengths to aid in softness and to provide improved aesthetic appearance to consumers.

Abstract: An absorbent article can be configured to adhere to the body of a wearer in the area of the body of the wearer that may need bodily fluids absorbed. The absorbent article can be adhered to the body of the wearer to or around the vulva region of the body. The absorbent article can have an absorbent assembly which has a variable height in the longitudinal direction of the absorbent article.

Abstract: An absorbent article including an absorbent core sandwiched between a liquid-permeable topsheet and a liquid-impermeable backsheet, the article defining a front portion, a back portion and a crotch portion, wherein the absorbent core includes an absorbent component enclosed by a core cover including an upper side and a lower side, and a sealing arrangement for joining the upper and lower core cover sides and including two channel sealings, in the crotch portion, defining a first channel sealing width and a second channel sealing width, and also including two side seams along the sides of the core, wherein a centre segment having a first width is defined in the absorbent component between the channel sealings and two side segments each having a second width are defined in the absorbent component outside each channel sealing.

Abstract: A drainage system, the drainage system comprising a container having an interior and a mouth, the mouth comprising an outer surface and an opening, a frangible seal covering the opening, a cap secured to the mouth and in fluid communication with a drainage line, the cap having an inner surface configured to engage with the outer surface of the mouth, an O-ring located at least partially between the outer surface of the mouth and the inner surface of the cap and configured to form a fluid seal between a space defined by the cap and the space located externally of the drainage system, and a retaining ring circumferentially engaging the cap.

Abstract: A negative pressure assembly includes a drape, a sealing element, a reactor, and a mechanical pump assembly. The drape covers a dressing site on a patient and seals against the skin upon application of a vacuum while maintaining a negative pressure underneath the drape. When applied to the skin, the sealing element cooperates with the drape to define an enclosed volume covered by the drape and surrounded by the sealing element. The reactor is located with respect to the drape and the sealing element to be in fluid communication with the enclosed volume when the drape is covering the dressing site and is configured to react with and consume a selected gas found in air. The mechanical pump assembly is connectable to the enclosed volume and has a pump chamber in fluid communication with the enclosed volume to draw air from the enclosed volume into the pump chamber.

Abstract: A system for use in venting a gas from an interior of an ostomy collection pouch is described. The system is removable and/or reusable in other medical devices. A flange is configured to affix the system to a hole in a wall of the ostomy collection pouch. The flange may have a straight or a curved configuration. In examples, the flange has a 90 degree configuration. Further, the system includes a manual or a passive filter to remove odor from the gas.

Abstract: The disclosed technology relates to a wound dressing comprising a vertically lapped material. The disclosed technology further relates to methods and uses of the wound dressing.

Abstract: Embodiments disclosed herein are directed to negative pressure treatment systems and wound dressing systems, apparatuses, and methods that may be used for the treatment of wounds. In particular, some embodiments are directed to improved wound dressings comprising an obscuring layer that may hide fluid contained therein. Some embodiments may further comprise one or more viewing windows disposed therethrough so as to enable monitoring or examination of fluids contained therein.

Abstract: Various systems and methods are provided for reducing pressure at an outflow of a duct such as the thoracic duct or the lymphatic duct. A catheter system can include a catheter shaft configured to be at least partially implantable within a patient's vein, a flexible membrane attached to the catheter shaft, the flexible membrane being a collapsible, tube-like member having a lumen extending therethrough, and a single selectively deployable restriction member formed over a portion of the flexible membrane at substantially a midpoint between a proximal end of the flexible membrane and a distal end of the flexible membrane, the restriction member being configured to control a size of the lumen so as to direct a controlled volume of fluid from an upstream side of the restriction member to a downstream side the restriction member.

Abstract: Apparatus and methods are provided for treating diseases that produce elevated intraocular pressures, such as glaucoma, wherein the device includes a housing shell defining a cavity between a first end and a second end of the housing shell, and an elastic membrane disposed within the cavity to divide the cavity into a fluidic channel that permits a flow of fluid from the first end to the second end and a sealed cavity. The elastic membrane deforms to change the volume of the sealed cavity responsive to pressure fluctuations between the first and second ends, thereby varying the fluidic resistance of the flow of fluid through the fluidic channel.

Abstract: Embodiments of a method for removing a tattoo through patterned trans-epidermal pigment release includes determining first treatment area of skin of a patient through a primary template including primary apertures, marking the first treatment area of skin of the patient along borders of the primary apertures to outline a grid of primary tegulae, and delivering a tattoo removal fluid to the marked first exposed skin. In an alternate embodiment, a template, which may be adhered to the skin, is used during a microneedling process to create a structured, patterned procedure to remove skin irregularities. The template has a plurality of needle apertures, an adhesive layer, and a release liner. The release liner may be removed, exposing the adhesive layer, so that the template, with the plurality of needle apertures, may be positioned over the skin irregularity.

Abstract: A dialysate mixing machine may be configured to make dialysate on demand using, among other things, a plurality of concentrates in solid tablet form. For example, a prescription may be received by the dialysate mixing machine indicating the particular chemical constituents and amounts of each chemical constituent to be included in the dialysate. Based on the prescription, the dialysate mixing machine can determine the number of tablets required for each chemical constituent (and, e.g., the required amounts of other chemical constituents that are not in tablet form). The tablets are automatically dispensed and mixed with purified water, bicarbonate, and sodium chloride in a mixing chamber to produce the dialysate according to the prescription. The dialysate mixing machine may be used with and/or coupled to a dialysis machine (e.g., a hemodialysis (HD) machine designed for home use) to provide the dialysate on demand for a dialysis treatment.

Abstract: A ventricular shunt assembly, used in conjunction with a hyperbaric environment (e.g., having a pressure of about 250 to about 350 mm H2O above atmospheric pressure) can be used to correct a patient's intraparenchymal venous pressure from a sub-normally low value to a normal value. The shunt may comprise a valve, e.g., and adjustable valve, disposed between the ventricular catheter and the distal catheter. Optionally, the shunt comprises a reservoir on the ventricular side of the valve.

Abstract: A negative pressure wound therapy device can include a negative pressure source and a controller configured to activate the negative pressure source for a first duration of time to attempt to reduce pressure under the wound dressing to approximately a negative pressure set point, subsequent to expiration of the first duration of time, deactivate the negative pressure source after pressure under the wound dressing is reduced to approximately the negative pressure set point, activate the negative pressure source for a second duration of time to attempt to reduce pressure in the fluid flow path, the second duration of time subsequent to the first duration of time, determine a pressure change in a fluid flow path over the second duration of time, and, in response to determining that the pressure change in the fluid flow path over the second duration of time indicates reduction in pressure, provide indication of a blockage.

Abstract: A puncture needle connector (1) includes an outer cylinder (11), an inner cavity (1a) formed within the outer cylinder (11), an arm (15) provided at the outer cylinder (11), the arm (15) being elastically deformable by bending, and a claw (16) provided on the arm (15). The inner cavity (1a) is in communication with the outside via a first opening (21) and a second opening (22). When a puncture needle (210) is inserted into the inner cavity (1a) via a first opening (21), the claw (16) engages with an engagement structure (217) provided integrally with the puncture needle (210), a liquid-tight seal (25) is formed between an outer circumferential surface of the puncture needle (210) and an inner circumferential surface of the inner cavity (1a), and the puncture needle (210) and the second opening (22) are in communication with the each other.

Abstract: A tubeset module includes one or more elements of a negative pressure wound therapy (“NPWT”) system, such as a valve, a calibrated leak, a pressure sensor, etc. The tubeset module may communicate with a controller of the NPWT system via a communications interface provided by the tubeset module. The communication between the tubeset module and the controller may be used to fully automate one or more processes involving the operation of the components of the NPWT system included in the tubeset module, allowing the NPWT system to, e.g. estimate a wound site volume, estimate a volume of fluid to be instilled, monitor wound healing progression, etc. without requiring any user interaction or involvement. The tubeset module may be defined by one or more housing elements. The tubeset module may be incorporated into any of the tubing, fluid canister, wound dressing and/or therapy device housing components of the NPWT system.

Abstract: Flexible polyurethane (PU) material which comprises a flexible hydrophilic polyurethane foam porous matrix comprising two matrix faces and therebetween a structural matrix framework defining a network of cells, having a cell network surface and therein a network of pores and a powder charge comprising one or more additives loaded in said structural matrix framework wherein said material is a foamed polymer of a system comprising an isocyanate prepolymer or monomer phase and an aqueous phase, wherein said system comprises one or more slurry phases or solid concentrates of said powder charge, or an insoluble portion thereof, as said isocyanate phase or part thereof and/or as said aqueous phase or part thereof and/or in a carrier liquid phase; and/or comprising a powder charge of silver salt loaded in said structural matrix framework in a population of silver salt particles defined by particle size distribution about a mean particle size of greater than or equal to 1 micron, said material comprising silver salt

Abstract: The present invention is a device for holding an ophthalmic bottle of drops and instilling them in a patient's eye. The device rests on the boney lower orbital ridge for stability and correct delivery.